Cases and resources in vascular techniques
This section provides a selection of cases and resources provided by experts in vascular techniques.
By watching this session, you will learn the following:
By watching this session, you will learn the following:
By watching this session, you will learn the following:
This PVI 2025 late-breaking trials session delivers key updates in limb ischemia, spanning acute, chronic, and no-option CLTI. The presentations highlight the efficacy and safety of contemporary endovascular devices, clarify long-term outcomes of drug-coated and drug-eluting technologies, and provide real-world evidence supporting evolving revascularisation strategies across complex PAD populations.
Dr. Per Skoog reviews the SWEDEPAD I and II trials, the largest PAD studies evaluating drug-eluting devices. SWEDEPAD I focused on CLTI patients, SWEDEPAD II on claudicants. Both studies showed no improvement in patient-centered outcomes compared with non-coated devices. These findings highlight that drug-eluting devices did not provide added benefit, offering key insights for everyday PAD management.
The PVI 2025 session covers access strategies, lesion preparation, near-occlusion and restenosis management, TCAR in challenging patients, and carotid dissections. Practical insights and advanced techniques are shared to tailor interventions to each patient.
This PVI 2025 session tackles some of the most persistent questions in endovascular therapy — from choosing CERAB or kissing stents for AIOD, to whether CFA guidelines are pushing boundaries or still holding back progress. It reviews the ongoing debate around stenting in distal popliteal disease, highlights what the SWEDEPAD RCT means for daily practice, and revisits the long-standing promise of resorbable scaffolds. A compact tour of key controversies shaping treatment choices today.
